Compare XNCR & UXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XNCR | UXIN |
|---|---|---|
| Founded | 1997 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 756.6M |
| IPO Year | 2013 | 2018 |
| Metric | XNCR | UXIN |
|---|---|---|
| Price | $13.52 | $3.74 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $22.78 | N/A |
| AVG Volume (30 Days) | ★ 429.4K | 200.1K |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,576,000.00 | N/A |
| Revenue This Year | $18.68 | $237.18 |
| Revenue Next Year | N/A | $145.46 |
| P/E Ratio | ★ N/A | $4.05 |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $6.92 | $2.45 |
| 52 Week High | $18.69 | $5.40 |
| Indicator | XNCR | UXIN |
|---|---|---|
| Relative Strength Index (RSI) | 60.87 | 58.95 |
| Support Level | $12.57 | $3.63 |
| Resistance Level | $15.59 | $3.77 |
| Average True Range (ATR) | 0.83 | 0.22 |
| MACD | 0.24 | 0.02 |
| Stochastic Oscillator | 70.96 | 85.44 |
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.